Join to access to all OVN content. Join for Free
Why MSLs Need a Personal Board of Directors
Medical Science Liaisons personal board of directors MSL career development mentorship in medical affairs Medical Affairs Executive Coach

Why MSLs Need a Personal Board of Directors


Share This Article


Summary

In this episode, Tom Caravela welcomes Marieke Jonkman to discuss the concept of creating a personal board of directors for Medical Science Liaisons (MSLs). Marieke shares her career journey and emphasizes the importance of selecting and approaching the right individuals to form a supportive board. The conversation covers the roles and expectations of board members in an MSL's development, highlighting the reciprocal nature of mentorship and the involvement of managers. Marieke also provides insights on maintaining and nurturing these crucial relationships. The episode concludes with closing remarks and a call to action for listeners to engage with the MSL Talk community.

My guest today is Marieke Jonkman, Medical Affairs Executive Coach at the Medical Affairs Institute and we discuss why MSLs should have their own personal board of directors

Marieke discusses…

๐Ÿ‘‰ What would a personal board of directors look like
๐Ÿ‘‰ How to go about finding people for your PBD
๐Ÿ‘‰ Who you should ask to be on your board
๐Ÿ‘‰ How to approach a potential board member

Click for Source
Medical Science Liaisons, personal board of directors, MSL career development, mentorship in medical affairs, Medical Affairs Executive Coach

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
Social Media Listening Evolved
Partner Avatar MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson

Social Media Listening Evolved

Podcast
How to Start Presenting Like a Pro
Partner Avatar MSL Talk: Tom Caravela

How to Start Presenting Like a Pro

Article
Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis
OVN Avatar Jayson L. Parker, Sebnem S. Kuzulugil, Kirill Pereverzev, Stephen Mac, Gilberto Lopes, Zain Shah, Ashini Weerasinghe, Daniel Rubinger, Adam Falconi, Ayse Bener, Bora Caglayan, Rohan Tangri, Nicholas Mitsakakis

Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis

Article
Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval
OVN Avatar Avi Cherla, MSc; Huseyin Naci, MHS, PhD; Aaron S. Kesselheim, MD, JD, MPH; Bishal Gyawali, MD, PhD; Elias Mossialos, MD, PhD

Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval

Article
Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review
OVN Avatar Vanessa Arciero, BS, Seanthel Delos Santos, Liza Koshy

Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review

Article
Clinical Educator Oncology Program Improves Adherence by 29%โ€‹
Partner Avatar iNIZIO

Clinical Educator Oncology Program Improves Adherence by 29%โ€‹

Explore OVN